Want to see MWAI full AI Analyst Report?
MWAI Stock Chart & Stats
$0.72
--
Market closed
$0.72
--
Day’s Range― - ―
52-Week Range$0.20 - $0.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)4.51K
Market Cap
$2.42M
Enterprise Value$2.07M
Total Cash (Recent Filing)$223.22K
Total Debt (Recent Filing)$600.30K
Price to Earnings (P/E)―
Beta0.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding6,536,580
10 Day Avg. Volume2,376
30 Day Avg. Volume4,515
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.81
Price to Sales (P/S)3.42
P/FCF Ratio-2.17
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue3.00
Enterprise Value/Gross Profit3.53
Enterprise Value/Ebitda-0.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Absolute DebtModest nominal debt (about $0.6M in 2025) reduces interest burden and lowers fixed financing costs versus highly leveraged peers. Structurally, low dollar leverage gives the company greater flexibility in financing choices and more runway to execute operational adjustments without heavy debt servicing pressure.
Expanded Preferred Equity CapacityAuthorizing 50% more Series B convertible preferred shares is a structural corporate action that increases the company's capacity to raise non-debt capital. This durable financing option can support operations or product development without adding bank debt, improving long-term fundraising flexibility though it may affect dilution dynamics.
Improving Cash Burn TrendA meaningful reduction in cash burn between 2024 and 2025 indicates management executed cost controls or efficiency measures that improved cash flow dynamics. While cash flow remains negative, a sustained trend of lower burn is a durable fundamental improvement that increases the probability of reaching self-funding if maintained.
Bears Say
Negative Shareholder EquityPersistent negative shareholder equity (2023–2025) is a foundational solvency concern that restricts access to traditional financing, weakens creditor confidence, and limits strategic options. Without recapitalization, negative equity materially increases long-term financial risk and constrains the firm's ability to absorb shocks or scale investments.
Consistent Cash Flow DeficitsOngoing negative operating and free cash flow across multiple years shows the business is not self-funding and depends on external financing. Structurally, persistent cash deficits raise dilution and refinancing risk, limit reinvestment capability, and impair the company's capacity to execute longer-term growth initiatives without repeated capital raises.
Volatile Revenue & Deep LossesHighly volatile top-line performance and a ~61% revenue drop in 2025 signal unstable demand or execution failures that undermine scalability. Coupled with extremely negative net margins (about -606%), this indicates the cost structure does not flex with sales, threatening sustainable profitability unless revenue stabilizes and costs are significantly restructured.
MedWellAI News
MWAI FAQ
What was MedWellAI’s price range in the past 12 months?
MedWellAI lowest stock price was $0.20 and its highest was $0.80 in the past 12 months.
What is MedWellAI’s market cap?
MedWellAI’s market cap is $2.42M.
When is MedWellAI’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MedWellAI’s earnings last quarter?
MedWellAI released its earnings results on Feb 18, 2025. The company reported -$0.127 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.127.
Is MedWellAI overvalued?
According to Wall Street analysts MedWellAI’s price is currently Overvalued.
Does MedWellAI pay dividends?
MedWellAI does not currently pay dividends.
What is MedWellAI’s EPS estimate?
MedWellAI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedWellAI have?
MedWellAI has 6,536,580 shares outstanding.
What happened to MedWellAI’s price movement after its last earnings report?
MedWellAI reported an EPS of -$0.127 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MedWellAI?
Currently, no hedge funds are holding shares in MWAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedWellAI
MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management. In addition, it provides an AI-powered ordering system with inventory tracking, smart suggestions, and support for healthcare providers such as wellness clinics, med spas, and corporate wellness facilities. The company was formerly known as Integrated Ventures, Inc. and changed its name to MedWellAI Inc. in June 2025. The company is based in Clearwater, Florida.
Technical Analysis
Nvni Group
―
Xiao-I Corp. ADR
―
Simpple Ltd.
―
Health In Tech, Inc. Class A
―
Cloudastructure, Inc. Class A
―